Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate
Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular develo...
Saved in:
| Published in | Contraception (Stoneham) Vol. 79; no. 3; pp. 182 - 188 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Elsevier Inc
01.03.2009
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0010-7824 1879-0518 1879-0518 |
| DOI | 10.1016/j.contraception.2008.10.005 |
Cover
| Abstract | Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate.
Forty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7.
Sixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups.
In contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC. |
|---|---|
| AbstractList | Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate.BACKGROUNDCombined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate.Forty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7.STUDY DESIGNForty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7.Sixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups.RESULTSSixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups.In contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC.CONCLUSIONIn contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC. Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate. Forty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7. Sixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups. In contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC. Abstract Background Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular development, which can be managed by shortening the number of hormone-free days per COC cycle. This study evaluates differences in follicular development during a 7-day versus 4-day hormone-free interval in a COC regimen with 20 mcg EE and 1 mg norethindrone acetate. Study Design Forty-one healthy women were randomized in an open-label fashion to this formulation in either a 24/4 or a 21/7 day regimen for three cycles. Estradiol, progesterone, follicle-stimulating hormone, luteinizing hormone and inhibin B were measured daily from Cycle 2, Day 21 to Cycle 3, Day 3 and on Day 7 of Cycle 3. Follicular diameter and Hoogland score were calculated on Cycle 2, Days 21, 24 and 28 and Cycle 3, Days 3 and 7. Results Sixty-six percent of subjects in the 21/7 group and 70% of the subjects in the 24/4 group developed a follicle greater than 10 mm diameter. Ovarian steroid hormone levels, Hoogland scores and bleeding patterns were not statistically significant between the groups. Conclusion In contrast to prior studies, this analysis suggests no difference in follicle development or bleeding patterns among women receiving a 21/7 or 24/4 regimen of a 20-mcg EE/1-mg norethindrone acetate COC. |
| Author | Wilson, Melissa L. Taylor, DeShawn Mishell, Daniel R. Rible, Radhika D. Stanczyk, Frank Z. |
| Author_xml | – sequence: 1 givenname: Radhika D. surname: Rible fullname: Rible, Radhika D. email: r.rible@gmail.com – sequence: 2 givenname: DeShawn surname: Taylor fullname: Taylor, DeShawn – sequence: 3 givenname: Melissa L. surname: Wilson fullname: Wilson, Melissa L. – sequence: 4 givenname: Frank Z. surname: Stanczyk fullname: Stanczyk, Frank Z. – sequence: 5 givenname: Daniel R. surname: Mishell fullname: Mishell, Daniel R. |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21151254$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19185670$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNktuKFDEQhhtZcWdXX0EConc9VtKdPiAIy7CrwoIX6nVIJzUzGdPJmHS3zOv4pGYOnhaEuQpF_f-XSv25yi6cd5hlLyjMKdDq9WauvBuCVLgdjHdzBtCkzhyAP8pmtKnbHDhtLrIZAIW8blh5mV3FuAGAuuX1k-yStrThVQ2z7Medt9ao0cpANE5o_bZHNxDjiCR1ruWOTBjiGEl5KNY-9GmcfBkQk2jAMElLvpthTaQjPqTir-kmPFTSOONWhAHp1YrgsDZuZwnGJNPG2-TUhJJ-RZwPh64O6Q6SGIMc8Gn2eCltxGen8zr7cnf7efE-v__47sPi5j5XnFVDrtqOF6ixYgyXlBUci6KqZdE2LddatVCVnaqhRihp18kiHW3Xyg4Z1JxpKK6zV0fuNvhvY5pO9CYqtFY69GMUVdUkOy-S8PlJOHY9arENppdhJ35tNQlengQyKmmXQTpl4m8do5RTxsuke3PUqeBjDLj8gwKxz1psxD9Zi33W-2bKOrlvHriVSfsyB4OxZzJujwxMi50MBhGVQadQm4BqENqbMzlvH3CUTaGnx3_FHcaNH4NL2QkqIhMgPu1_5v5jQgNQNhVNgMX_AWeP8RPoU_6X |
| CODEN | CCPTAY |
| CitedBy_id | crossref_primary_10_1136_bmjsrh_2018_CHC crossref_primary_10_1177_0024363918815611 crossref_primary_10_3109_13625187_2014_979282 crossref_primary_10_1016_j_contraception_2012_12_006 crossref_primary_10_1146_annurev_pharmtox_031120_015212 crossref_primary_10_1007_s00404_012_2545_6 crossref_primary_10_15585_mmwr_rr7303a1 crossref_primary_10_1016_j_rbmo_2016_07_010 crossref_primary_10_1093_aje_kwq388 crossref_primary_10_1093_humrep_dev115 crossref_primary_10_1136_bmjsem_2021_001047 crossref_primary_10_1136_jfprhc_2013_100600 crossref_primary_10_1016_j_ajog_2012_04_022 crossref_primary_10_1097_AOG_0b013e3181e79440 |
| Cites_doi | 10.3109/13625189909043474 10.1080/ejc.6.2.108.114 10.1016/S0010-7824(02)00344-X 10.1095/biolreprod.103.017772 10.1016/0010-7824(93)90025-3 10.1016/j.contraception.2006.02.006 10.1016/j.contraception.2004.05.013 10.1016/S0010-7824(97)00174-1 10.1016/S0002-9378(98)70292-3 10.1080/gye.17.2.107.114 10.1016/j.maturitas.2004.01.001 10.1016/0002-9378(77)90733-5 10.1016/0010-7824(96)00137-0 10.1016/S0010-7824(99)00025-6 10.1016/S0015-0282(99)00205-8 10.1016/S0010-7824(99)00094-3 10.1016/S0002-9378(99)70364-9 10.1016/j.contraception.2004.05.006 10.1016/S0010-7824(97)00157-1 10.1016/S0029-7844(99)00524-4 10.1016/j.contraception.2006.08.004 10.1016/S0010-7824(01)00235-9 10.1016/j.steroids.2003.08.003 10.1016/j.contraception.2005.08.021 10.1016/S0010-7824(00)00098-6 10.1016/j.contraception.2007.01.014 10.1097/01.AOG.0000175834.77215.2e 10.1016/j.contraception.2004.12.012 |
| ContentType | Journal Article |
| Copyright | 2009 Elsevier Inc. Elsevier Inc. 2009 INIST-CNRS |
| Copyright_xml | – notice: 2009 Elsevier Inc. – notice: Elsevier Inc. – notice: 2009 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.contraception.2008.10.005 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-0518 |
| EndPage | 188 |
| ExternalDocumentID | 19185670 21151254 10_1016_j_contraception_2008_10_005 S0010782408004861 1_s2_0_S0010782408004861 |
| Genre | Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEC HMK HMO HVGLF HZ~ IHE J1W KOM M29 M2X M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K VH1 WUQ Z5R ZGI ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG 0SF AAIAV AAYXX CITATION AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c526t-c9b53ede622ef1235e3367a39895ddc9064bc707e041bba30419b9abe20752d03 |
| IEDL.DBID | AIKHN |
| ISSN | 0010-7824 1879-0518 |
| IngestDate | Thu Oct 02 11:43:57 EDT 2025 Wed Feb 19 01:44:03 EST 2025 Mon Jul 21 09:14:01 EDT 2025 Thu Apr 24 23:11:02 EDT 2025 Wed Oct 01 03:39:50 EDT 2025 Tue Jul 09 07:17:48 EDT 2024 Sun Feb 23 10:18:56 EST 2025 Tue Oct 14 19:37:00 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Oral contraceptive Shortened hormone-free interval Follicular development Ethinylestradiol Human Estrogen Oral administration Administration schedule Ovulation Progestagen Follicular phase Dose activity relation Treatment withdrawal Female Contraceptive Norethisterone Woman Comparative study Interval |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c526t-c9b53ede622ef1235e3367a39895ddc9064bc707e041bba30419b9abe20752d03 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| PMID | 19185670 |
| PQID | 66870753 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_66870753 pubmed_primary_19185670 pascalfrancis_primary_21151254 crossref_primary_10_1016_j_contraception_2008_10_005 crossref_citationtrail_10_1016_j_contraception_2008_10_005 elsevier_sciencedirect_doi_10_1016_j_contraception_2008_10_005 elsevier_clinicalkeyesjournals_1_s2_0_S0010782408004861 elsevier_clinicalkey_doi_10_1016_j_contraception_2008_10_005 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-03-01 |
| PublicationDateYYYYMMDD | 2009-03-01 |
| PublicationDate_xml | – month: 03 year: 2009 text: 2009-03-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States |
| PublicationTitle | Contraception (Stoneham) |
| PublicationTitleAlternate | Contraception |
| PublicationYear | 2009 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Baerwald, Olatunbosun, Pierson (bib6) 2004; 70 Spona, Elstien, Feichtinger (bib23) 1996; 54 Bachmann, Sulak, Sampson-Landers, Benda, Marr (bib20) 2004; 70 Van Heusden, Fauser (bib1) 1999; 59 Elomaa, Lähteenmäki (bib4) 1999; 60 Mishell (bib22) 2005; 71 Kuhnz, Huener, Humpel, Seifert, Michaelis (bib28) 1997; 56 Coffee, Sulak, Kuehl (bib16) 2007; 75 Pearlstein, Bachmann, Zacur, Yonkers (bib21) 2005; 72 Hite, Bannemerschult, Fox-Kuchenbecker, Turck, Brill (bib3) 1999; 4 Hoogland, Skouby (bib11) 1993; 47 Endrikat, Gerlinger, Plettig (bib12) 2003; 17 Sitruk-Ware (bib27) 2004; 47 Vree, Schmidt (bib18) 2001; 6 Grimes, Godwin, Rubin, Smith, Lacarra (bib8) 1994; 83 Baerwald, Adams, Pierson (bib10) 2003; 69 Nakajima, Archer, Ellman (bib17) 2007; 75 Bannemerschult, Hanker, Wünsch (bib2) 1997; 56 Jain, Ota, Mishell (bib7) 2000; 61 Willis, Kuehl, Spiekerman, Sulak (bib25) 2006; 74 Endrikat, Cronin, Gerlinger, Reubig, Schmidt, Düsterberg (bib29) 2001; 64 Brenner, Mishell, Stanczyk, Gobelsmann (bib14) 1977; 129 Stanczyk (bib26) 2003; 68 Killick, Fitzgerald, Davis (bib19) 1998; 179 Sullivan, Furniss, Spona, Elstein (bib24) 1999; 72 Sulak, Scow, Preece, Riggs, Kuehl (bib13) 2000; 95 Coney, Del Conte (bib9) 1999; 181 Creinin, Lippman, Eder, Godwin, Olson (bib5) 2002; 66 Yonkers, Brown, Pearlstein, Foegh, Sampson-Landers, Rapkin (bib15) 2005; 106 Sullivan (10.1016/j.contraception.2008.10.005_bib24) 1999; 72 Jain (10.1016/j.contraception.2008.10.005_bib7) 2000; 61 Creinin (10.1016/j.contraception.2008.10.005_bib5) 2002; 66 Baerwald (10.1016/j.contraception.2008.10.005_bib6) 2004; 70 Yonkers (10.1016/j.contraception.2008.10.005_bib15) 2005; 106 Grimes (10.1016/j.contraception.2008.10.005_bib8) 1994; 83 Sulak (10.1016/j.contraception.2008.10.005_bib13) 2000; 95 Bachmann (10.1016/j.contraception.2008.10.005_bib20) 2004; 70 Killick (10.1016/j.contraception.2008.10.005_bib19) 1998; 179 Bannemerschult (10.1016/j.contraception.2008.10.005_bib2) 1997; 56 Spona (10.1016/j.contraception.2008.10.005_bib23) 1996; 54 Nakajima (10.1016/j.contraception.2008.10.005_bib17) 2007; 75 Van Heusden (10.1016/j.contraception.2008.10.005_bib1) 1999; 59 Endrikat (10.1016/j.contraception.2008.10.005_bib29) 2001; 64 Coney (10.1016/j.contraception.2008.10.005_bib9) 1999; 181 Brenner (10.1016/j.contraception.2008.10.005_bib14) 1977; 129 Willis (10.1016/j.contraception.2008.10.005_bib25) 2006; 74 Hite (10.1016/j.contraception.2008.10.005_bib3) 1999; 4 Sitruk-Ware (10.1016/j.contraception.2008.10.005_bib27) 2004; 47 Mishell (10.1016/j.contraception.2008.10.005_bib22) 2005; 71 Coffee (10.1016/j.contraception.2008.10.005_bib16) 2007; 75 Elomaa (10.1016/j.contraception.2008.10.005_bib4) 1999; 60 Kuhnz (10.1016/j.contraception.2008.10.005_bib28) 1997; 56 Endrikat (10.1016/j.contraception.2008.10.005_bib12) 2003; 17 Hoogland (10.1016/j.contraception.2008.10.005_bib11) 1993; 47 Vree (10.1016/j.contraception.2008.10.005_bib18) 2001; 6 Pearlstein (10.1016/j.contraception.2008.10.005_bib21) 2005; 72 Stanczyk (10.1016/j.contraception.2008.10.005_bib26) 2003; 68 Baerwald (10.1016/j.contraception.2008.10.005_bib10) 2003; 69 |
| References_xml | – volume: 56 start-page: 379 year: 1997 end-page: 385 ident: bib28 article-title: In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women publication-title: Contraception – volume: 68 start-page: 879 year: 2003 end-page: 890 ident: bib26 article-title: All progestins are not created equal publication-title: Steroids – volume: 72 start-page: 414 year: 2005 end-page: 421 ident: bib21 article-title: Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation publication-title: Contraception – volume: 47 start-page: 277 year: 2004 end-page: 283 ident: bib27 article-title: Pharmacological profile of progestins publication-title: Maturitas – volume: 181 start-page: S53 year: 1999 end-page: S58 ident: bib9 article-title: The effects on ovarian activity of a monophasic oral contraceptive with 100 mcg levonorgestrel and 20 mcg ethinyl estradiol publication-title: Am J Obstet Gynecol – volume: 72 start-page: 115 year: 1999 end-page: 120 ident: bib24 article-title: Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 mcg) and ethinyl estradiol (15 mcg) on ovarian activity publication-title: Fertil Steril – volume: 179 start-page: S18 year: 1998 end-page: S24 ident: bib19 article-title: Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval publication-title: Am J Obstet Gynecol – volume: 56 start-page: 285 year: 1997 end-page: 290 ident: bib2 article-title: A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low-dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles publication-title: Contraception – volume: 74 start-page: 100 year: 2006 end-page: 103 ident: bib25 article-title: Greater inhibition of the pituitary–ovarian axis in oral contraceptive regimens with a shortened hormone-free interval publication-title: Contraception – volume: 95 start-page: 261 year: 2000 end-page: 266 ident: bib13 article-title: Hormone withdrawal symptoms in oral contraceptive users publication-title: Obstet Gynecol – volume: 60 start-page: 275 year: 1999 end-page: 279 ident: bib4 article-title: Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment publication-title: Contraception – volume: 71 start-page: 304 year: 2005 end-page: 305 ident: bib22 article-title: Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations publication-title: Contraception – volume: 6 start-page: 108 year: 2001 end-page: 114 ident: bib18 article-title: A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany publication-title: Eur J Contracept Reprod Health Care – volume: 47 start-page: 583 year: 1993 end-page: 590 ident: bib11 article-title: Ultrasound evaluation of ovarian activity under oral contraceptives publication-title: Contraception – volume: 61 start-page: 195 year: 2000 end-page: 198 ident: bib7 article-title: Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive publication-title: Contraception – volume: 129 start-page: 133 year: 1977 end-page: 140 ident: bib14 article-title: Serum levels of publication-title: Am J Obstet Gynecol – volume: 70 start-page: 371 year: 2004 end-page: 377 ident: bib6 article-title: Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use publication-title: Contraception – volume: 54 start-page: 71 year: 1996 end-page: 77 ident: bib23 article-title: Shorter pill-free interval in combined oral contraceptives decreases follicular development publication-title: Contraception – volume: 66 start-page: 147 year: 2002 end-page: 152 ident: bib5 article-title: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 mcg ethinyl estradiol versus monophasic levonorgestrel/20 mcg ethinyl estradiol publication-title: Contraception – volume: 75 start-page: 444 year: 2007 end-page: 449 ident: bib16 article-title: Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen publication-title: Contraception – volume: 106 start-page: 492 year: 2005 end-page: 501 ident: bib15 article-title: Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder publication-title: Am J Ob Gyn – volume: 64 start-page: 201 year: 2001 end-page: 207 ident: bib29 article-title: Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 mcg ethinyl estradiol and 75 mcg gestodene and a 21-day regimen with 20 mcg ethinyl estradiol and 150 mcg desogestrel publication-title: Contraception – volume: 59 start-page: 237 year: 1999 end-page: 243 ident: bib1 article-title: Activity of the pituitary–ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives publication-title: Contraception – volume: 4 start-page: 7 year: 1999 end-page: 13 ident: bib3 article-title: Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranova®) in Germany publication-title: Eur J Contracep Reprod Health Care – volume: 75 start-page: 16 year: 2007 end-page: 22 ident: bib17 article-title: Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 mcg (Loestrin 24 Fe) publication-title: Contraception – volume: 83 start-page: 29 year: 1994 end-page: 34 ident: bib8 article-title: Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial publication-title: Obstet Gynecol – volume: 70 start-page: 191 year: 2004 end-page: 198 ident: bib20 article-title: Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 mcg ethinylestradiol and 3 mg drospirenone publication-title: Contraception – volume: 69 start-page: 1023 year: 2003 end-page: 1031 ident: bib10 article-title: Characteristics of ovarian follicular wave dynamics in women publication-title: Biol Reprod – volume: 17 start-page: 107 year: 2003 end-page: 114 ident: bib12 article-title: A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use publication-title: Gynecol Endocrinol – volume: 4 start-page: 7 year: 1999 ident: 10.1016/j.contraception.2008.10.005_bib3 article-title: Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranova®) in Germany publication-title: Eur J Contracep Reprod Health Care doi: 10.3109/13625189909043474 – volume: 6 start-page: 108 year: 2001 ident: 10.1016/j.contraception.2008.10.005_bib18 article-title: A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany publication-title: Eur J Contracept Reprod Health Care doi: 10.1080/ejc.6.2.108.114 – volume: 66 start-page: 147 year: 2002 ident: 10.1016/j.contraception.2008.10.005_bib5 article-title: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 mcg ethinyl estradiol versus monophasic levonorgestrel/20 mcg ethinyl estradiol publication-title: Contraception doi: 10.1016/S0010-7824(02)00344-X – volume: 69 start-page: 1023 year: 2003 ident: 10.1016/j.contraception.2008.10.005_bib10 article-title: Characteristics of ovarian follicular wave dynamics in women publication-title: Biol Reprod doi: 10.1095/biolreprod.103.017772 – volume: 47 start-page: 583 year: 1993 ident: 10.1016/j.contraception.2008.10.005_bib11 article-title: Ultrasound evaluation of ovarian activity under oral contraceptives publication-title: Contraception doi: 10.1016/0010-7824(93)90025-3 – volume: 74 start-page: 100 year: 2006 ident: 10.1016/j.contraception.2008.10.005_bib25 article-title: Greater inhibition of the pituitary–ovarian axis in oral contraceptive regimens with a shortened hormone-free interval publication-title: Contraception doi: 10.1016/j.contraception.2006.02.006 – volume: 70 start-page: 191 year: 2004 ident: 10.1016/j.contraception.2008.10.005_bib20 article-title: Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 mcg ethinylestradiol and 3 mg drospirenone publication-title: Contraception doi: 10.1016/j.contraception.2004.05.013 – volume: 56 start-page: 379 year: 1997 ident: 10.1016/j.contraception.2008.10.005_bib28 article-title: In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women publication-title: Contraception doi: 10.1016/S0010-7824(97)00174-1 – volume: 179 start-page: S18 year: 1998 ident: 10.1016/j.contraception.2008.10.005_bib19 article-title: Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(98)70292-3 – volume: 17 start-page: 107 year: 2003 ident: 10.1016/j.contraception.2008.10.005_bib12 article-title: A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use publication-title: Gynecol Endocrinol doi: 10.1080/gye.17.2.107.114 – volume: 47 start-page: 277 year: 2004 ident: 10.1016/j.contraception.2008.10.005_bib27 article-title: Pharmacological profile of progestins publication-title: Maturitas doi: 10.1016/j.maturitas.2004.01.001 – volume: 129 start-page: 133 year: 1977 ident: 10.1016/j.contraception.2008.10.005_bib14 article-title: Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(77)90733-5 – volume: 54 start-page: 71 year: 1996 ident: 10.1016/j.contraception.2008.10.005_bib23 article-title: Shorter pill-free interval in combined oral contraceptives decreases follicular development publication-title: Contraception doi: 10.1016/0010-7824(96)00137-0 – volume: 59 start-page: 237 year: 1999 ident: 10.1016/j.contraception.2008.10.005_bib1 article-title: Activity of the pituitary–ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives publication-title: Contraception doi: 10.1016/S0010-7824(99)00025-6 – volume: 72 start-page: 115 year: 1999 ident: 10.1016/j.contraception.2008.10.005_bib24 article-title: Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 mcg) and ethinyl estradiol (15 mcg) on ovarian activity publication-title: Fertil Steril doi: 10.1016/S0015-0282(99)00205-8 – volume: 60 start-page: 275 year: 1999 ident: 10.1016/j.contraception.2008.10.005_bib4 article-title: Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment publication-title: Contraception doi: 10.1016/S0010-7824(99)00094-3 – volume: 181 start-page: S53 year: 1999 ident: 10.1016/j.contraception.2008.10.005_bib9 article-title: The effects on ovarian activity of a monophasic oral contraceptive with 100 mcg levonorgestrel and 20 mcg ethinyl estradiol publication-title: Am J Obstet Gynecol doi: 10.1016/S0002-9378(99)70364-9 – volume: 70 start-page: 371 year: 2004 ident: 10.1016/j.contraception.2008.10.005_bib6 article-title: Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use publication-title: Contraception doi: 10.1016/j.contraception.2004.05.006 – volume: 56 start-page: 285 year: 1997 ident: 10.1016/j.contraception.2008.10.005_bib2 article-title: A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low-dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles publication-title: Contraception doi: 10.1016/S0010-7824(97)00157-1 – volume: 95 start-page: 261 year: 2000 ident: 10.1016/j.contraception.2008.10.005_bib13 article-title: Hormone withdrawal symptoms in oral contraceptive users publication-title: Obstet Gynecol doi: 10.1016/S0029-7844(99)00524-4 – volume: 75 start-page: 16 year: 2007 ident: 10.1016/j.contraception.2008.10.005_bib17 article-title: Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 mcg (Loestrin 24 Fe) publication-title: Contraception doi: 10.1016/j.contraception.2006.08.004 – volume: 64 start-page: 201 year: 2001 ident: 10.1016/j.contraception.2008.10.005_bib29 article-title: Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 mcg ethinyl estradiol and 75 mcg gestodene and a 21-day regimen with 20 mcg ethinyl estradiol and 150 mcg desogestrel publication-title: Contraception doi: 10.1016/S0010-7824(01)00235-9 – volume: 68 start-page: 879 year: 2003 ident: 10.1016/j.contraception.2008.10.005_bib26 article-title: All progestins are not created equal publication-title: Steroids doi: 10.1016/j.steroids.2003.08.003 – volume: 72 start-page: 414 year: 2005 ident: 10.1016/j.contraception.2008.10.005_bib21 article-title: Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation publication-title: Contraception doi: 10.1016/j.contraception.2005.08.021 – volume: 61 start-page: 195 year: 2000 ident: 10.1016/j.contraception.2008.10.005_bib7 article-title: Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive publication-title: Contraception doi: 10.1016/S0010-7824(00)00098-6 – volume: 83 start-page: 29 year: 1994 ident: 10.1016/j.contraception.2008.10.005_bib8 article-title: Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial publication-title: Obstet Gynecol – volume: 75 start-page: 444 year: 2007 ident: 10.1016/j.contraception.2008.10.005_bib16 article-title: Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen publication-title: Contraception doi: 10.1016/j.contraception.2007.01.014 – volume: 106 start-page: 492 year: 2005 ident: 10.1016/j.contraception.2008.10.005_bib15 article-title: Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder publication-title: Am J Ob Gyn doi: 10.1097/01.AOG.0000175834.77215.2e – volume: 71 start-page: 304 year: 2005 ident: 10.1016/j.contraception.2008.10.005_bib22 article-title: Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations publication-title: Contraception doi: 10.1016/j.contraception.2004.12.012 |
| SSID | ssj0007957 |
| Score | 1.9680411 |
| Snippet | Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production and follicular... Abstract Background Combined oral contraceptive (COC) formulations with 20 mcg ethinyl estradiol (EE) have a greater incidence of ovarian hormone production... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 182 |
| SubjectTerms | Adolescent Adult Biological and medical sciences Birth control Contraceptives, Oral, Combined - administration & dosage Drug Administration Schedule Endometrium - drug effects Estradiol - blood Ethinyl Estradiol - administration & dosage Female Follicle Stimulating Hormone - blood Follicular development Genital system. Reproduction Gynecology. Andrology. Obstetrics Hormonal contraception Humans Inhibins - blood Luteinizing Hormone - blood Medical sciences Menstruation - drug effects Middle Aged Norethindrone - administration & dosage Norethindrone - analogs & derivatives Obstetrics and Gynecology Oral contraceptive Ovarian Follicle - diagnostic imaging Ovarian Follicle - drug effects Ovarian Follicle - growth & development Pharmacology. Drug treatments Progesterone - blood Shortened hormone-free interval Ultrasonography Young Adult |
| Title | Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0010782408004861 https://www.clinicalkey.es/playcontent/1-s2.0-S0010782408004861 https://dx.doi.org/10.1016/j.contraception.2008.10.005 https://www.ncbi.nlm.nih.gov/pubmed/19185670 https://www.proquest.com/docview/66870753 |
| Volume | 79 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1879-0518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007957 issn: 0010-7824 databaseCode: ACRLP dateStart: 19980701 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-0518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007957 issn: 0010-7824 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1879-0518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007957 issn: 0010-7824 databaseCode: AIKHN dateStart: 19980701 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-0518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007957 issn: 0010-7824 databaseCode: AKRWK dateStart: 19700101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ra9swEBddCmUwxp6d98gE21evfsiSPcaghIXsVcZYod-EZJ1bj9QJcTLol_0x-0t3suRkYSsE9snY5ixbj7vfWb-7I-Sl4SLJNbolRZ5qdFA0hApSFlagMgWZQWeuI8ie8Mkp-3CWne2RUR8LY2mVXvc7nd5pa3_lyPfm0byubYxvbO0bs5iH5dYF2kf7k-cDsn_8_uPkZK2QReESftp9XytwQF5saF4dI1x5ConjVnZsr-w6Q3VrrlrsvsrVvbgemHYGanyH3PbIkh67l79L9qC5Rw4--73z--TX2Obf7min1GyoQrRuqKIiNOqKWorGqqWsO7lANDtrIKwWALTuqJH4ePvflqqG2sB--sdX_YDuzNWboElEL8tzCsuLurmaUrD_U0w9m6KkoTG9PKeNDZ_Eu2aBbVB8hgW9D8jp-N230ST0FRrCMkv4MiwLnaVggCcJVDbqFtKUC5UWeZEZUxaId3QpIgERi7VWKR4KXSgNCSKVxETpQzJosJlHhKac8RJKrkWEPmdZoeNsFI8Nr5K84kwE5HU_HLL06cttFY2p7Hlq3-XWWLoCm7HNfpoFhK2F5y6Lx25ib_pxl32gKqpWidZmN3HxL3FovZpoZSzbREbyr6kckLdrya3VsHvTw61puv5q9PcR4mUsIM_7eStRodhdItXAbNVKzlGFoxMbkEM3nTc9ViC44yJ6_L9v94TcdJtylsr3lAyWixU8Q2y31ENy49XPeIgrePT105ehX8m_AWYyVS0 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1da9swFBWlg24wyj47d1sr2F692rI-4jEGoyxkW9unFvomJOu69UidECeDvuzH7JfuyrKTha0Q2FNwkmvZknx1jnXuvYS8dVKxgUVakg8yiwTFQmwg43EJRhgQDslcK5A9k6ML_vVSXG6R4z4WxssqO98ffHrrrbtvjrrePJpWlY_xTf36xj3m4QNPge5xwZRnYO9-rnQeKg_pPv2ur__7DnmzEnm1enDTCUiCsrLVeom7lqmHU9Ng55Wh6sXdsLRdnoaPyG6HK-mncOmPyRbUT8jOabdz_pT8Gvrs263olLqVUIhWNTVUxc7cUi_QWDSUtwfXiGUnNcTlDIBWrTAST-_f2lJTUx_WT_-4qx_QHoVqE5Ql9Ka4ojC_rurbMQX_NsVVkzFaOprSmyta--BJ_NXNsA2K5_CQ9xm5GH4-Px7FXX2GuBBMzuMityIDB5IxKH3MLWSZVCbLB7lwrsgR7dhCJQoSnlprMvzIbW4sMMQpzCXZc7JdYzMvCM0klwUU0qoEGWdRIm12RqZOlmxQSq4i8r4fDl10yct9DY2x7lVq3_XaWIbymqnPfSoiwpfG05DDYzOzD_246z5MFR2rxrVmM3P1L3NoOifR6FQ3TCf6r4kckY9Ly7VnYfOmD9am6fKuke0jwBM8Iof9vNXoTvwekalhsmi0lOjAkcJGZC9M51WP5QjtpEr2__fqDsn90fnpiT75cvbtJXkQtue8qO8V2Z7PFvAaUd7cHrRP8W-s61Rg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Follicular+development+in+a+7-day+versus+4-day+hormone-free+interval+with+an+oral+contraceptive+containing+20+mcg+ethinyl+estradiol+and+1+mg+norethindrone+acetate&rft.jtitle=Contraception+%28Stoneham%29&rft.au=Rible%2C+Radhika+D&rft.au=Taylor%2C+DeShawn&rft.au=Wilson%2C+Melissa+L&rft.au=Stanczyk%2C+Frank+Z&rft.date=2009-03-01&rft.issn=1879-0518&rft.eissn=1879-0518&rft.volume=79&rft.issue=3&rft.spage=182&rft_id=info:doi/10.1016%2Fj.contraception.2008.10.005&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00107824%2FS0010782409X00028%2Fcov150h.gif |